Eligibility Breast Cancer NCT00354302

Criteria
Beschreibung

Criteria

enrolled in and meets eligibility requirements for protocol can-ncic-ma27
Beschreibung

Enrollment in clinical trial | Clinical Trial Eligibility Criteria Fulfill

Datentyp

boolean

Alias
UMLS CUI [1]
C4041024
UMLS CUI [2,1]
C1516637
UMLS CUI [2,2]
C1550543
acceptable quality dual-energy x-ray absorptiometry (dexa) of the l1-l4 postero-anterior spine and hip within 12 weeks prior to randomization on protocol can-ncic-ma27
Beschreibung

Dual-Energy X-Ray Absorptiometry Lumbar spine Postero-Anterior | Dual-Energy X-Ray Absorptiometry Hip

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1510486
UMLS CUI [1,2]
C3887615
UMLS CUI [1,3]
C1996865
UMLS CUI [2,1]
C1510486
UMLS CUI [2,2]
C0019552
hormone receptor status:
Beschreibung

Hormone Receptor Status

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0449438
estrogen receptor- and/or progesterone receptor-positive tumor
Beschreibung

Estrogen receptor positive tumor | Progesterone receptor positive tumor

Datentyp

boolean

Alias
UMLS CUI [1]
C1562312
UMLS CUI [2]
C1562928
patient characteristics:
Beschreibung

Client Characteristics

Datentyp

boolean

Alias
UMLS CUI [1]
C0815172
female
Beschreibung

Gender

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
postmenopausal
Beschreibung

Postmenopausal state

Datentyp

boolean

Alias
UMLS CUI [1]
C0232970
no malabsorption syndrome
Beschreibung

Malabsorption Syndrome

Datentyp

boolean

Alias
UMLS CUI [1]
C0024523
no known cholecalciferol (vitamin d) deficiency, active hyper- or hypoparathyroidism, or paget's disease
Beschreibung

Cholecalciferol Deficiency | Vitamin D Deficiency | Hyperparathyroidism | Hypoparathyroidism | Paget's Disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0008318
UMLS CUI [1,2]
C0011155
UMLS CUI [2]
C0042870
UMLS CUI [3]
C0020502
UMLS CUI [4]
C0020626
UMLS CUI [5]
C1368019
no uncontrolled thyroid disease, cushing's disease, or other pituitary disease
Beschreibung

Thyroid Disease Uncontrolled | Cushing Syndrome | Pituitary Disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0040128
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0010481
UMLS CUI [3]
C0032002
no other bone disease (including osteomalacia or osteogenesis imperfecta)
Beschreibung

Bone Disease | Osteomalacia | Osteogenesis Imperfecta

Datentyp

boolean

Alias
UMLS CUI [1]
C0005940
UMLS CUI [2]
C0029442
UMLS CUI [3]
C0029434
prior concurrent therapy:
Beschreibung

Therapeutic procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111
more than 6 months since prior drugs (investigational or not), including bisphosphonates, for the prevention of osteoporosis (stratum i)
Beschreibung

Pharmaceutical Preparations Prevention of osteoporosis | Investigational New Drugs Prevention of osteoporosis | Diphosphonates Prevention of osteoporosis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C3650929
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C3650929
UMLS CUI [3,1]
C0012544
UMLS CUI [3,2]
C3650929
more than 12 months since prior and no concurrent anticonvulsants
Beschreibung

Anticonvulsants

Datentyp

boolean

Alias
UMLS CUI [1]
C0003286
more than 6 months since prior and no concurrent corticosteroids at doses > 5 mg/day of prednisone (or equivalent) for > 2 weeks
Beschreibung

Adrenal Cortex Hormones Dose Daily | Prednisone Dose Daily | Prednisone Equivalent Dose Daily

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0332173
UMLS CUI [2,1]
C0032952
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0332173
UMLS CUI [3,1]
C0032952
UMLS CUI [3,2]
C0205163
UMLS CUI [3,3]
C0178602
UMLS CUI [3,4]
C0332173
more than 12 months since prior and no concurrent anabolic steroids
Beschreibung

Anabolic steroids

Datentyp

boolean

Alias
UMLS CUI [1]
C0002744
no prior bisphosphonates (stratum ii)
Beschreibung

Diphosphonates

Datentyp

boolean

Alias
UMLS CUI [1]
C0012544
no concurrent sodium fluoride at daily doses ≥ 5 mg/day
Beschreibung

Sodium Fluoride Dose Daily

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0037508
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0332173
no long-term (i.e., > 6 months) use of coumarins
Beschreibung

Coumarins Long-term

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0010207
UMLS CUI [1,2]
C0443252
no concurrent drugs (investigational or not), including bisphosphonates, for the prevention of osteoporosis (for patients with no osteopenia or osteoporosis [stratum i])
Beschreibung

Pharmaceutical Preparations Prevention of osteoporosis | Investigational New Drugs Prevention of osteoporosis | Diphosphonates Prevention of osteoporosis | Osteopenia | Osteoporosis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C3650929
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C3650929
UMLS CUI [3,1]
C0012544
UMLS CUI [3,2]
C3650929
UMLS CUI [4]
C0029453
UMLS CUI [5]
C0029456

Ähnliche Modelle

Eligibility Breast Cancer NCT00354302

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Enrollment in clinical trial | Clinical Trial Eligibility Criteria Fulfill
Item
enrolled in and meets eligibility requirements for protocol can-ncic-ma27
boolean
C4041024 (UMLS CUI [1])
C1516637 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
Dual-Energy X-Ray Absorptiometry Lumbar spine Postero-Anterior | Dual-Energy X-Ray Absorptiometry Hip
Item
acceptable quality dual-energy x-ray absorptiometry (dexa) of the l1-l4 postero-anterior spine and hip within 12 weeks prior to randomization on protocol can-ncic-ma27
boolean
C1510486 (UMLS CUI [1,1])
C3887615 (UMLS CUI [1,2])
C1996865 (UMLS CUI [1,3])
C1510486 (UMLS CUI [2,1])
C0019552 (UMLS CUI [2,2])
Hormone Receptor Status
Item
hormone receptor status:
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
Estrogen receptor positive tumor | Progesterone receptor positive tumor
Item
estrogen receptor- and/or progesterone receptor-positive tumor
boolean
C1562312 (UMLS CUI [1])
C1562928 (UMLS CUI [2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Gender
Item
female
boolean
C0079399 (UMLS CUI [1])
Postmenopausal state
Item
postmenopausal
boolean
C0232970 (UMLS CUI [1])
Malabsorption Syndrome
Item
no malabsorption syndrome
boolean
C0024523 (UMLS CUI [1])
Cholecalciferol Deficiency | Vitamin D Deficiency | Hyperparathyroidism | Hypoparathyroidism | Paget's Disease
Item
no known cholecalciferol (vitamin d) deficiency, active hyper- or hypoparathyroidism, or paget's disease
boolean
C0008318 (UMLS CUI [1,1])
C0011155 (UMLS CUI [1,2])
C0042870 (UMLS CUI [2])
C0020502 (UMLS CUI [3])
C0020626 (UMLS CUI [4])
C1368019 (UMLS CUI [5])
Thyroid Disease Uncontrolled | Cushing Syndrome | Pituitary Disease
Item
no uncontrolled thyroid disease, cushing's disease, or other pituitary disease
boolean
C0040128 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0010481 (UMLS CUI [2])
C0032002 (UMLS CUI [3])
Bone Disease | Osteomalacia | Osteogenesis Imperfecta
Item
no other bone disease (including osteomalacia or osteogenesis imperfecta)
boolean
C0005940 (UMLS CUI [1])
C0029442 (UMLS CUI [2])
C0029434 (UMLS CUI [3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Pharmaceutical Preparations Prevention of osteoporosis | Investigational New Drugs Prevention of osteoporosis | Diphosphonates Prevention of osteoporosis
Item
more than 6 months since prior drugs (investigational or not), including bisphosphonates, for the prevention of osteoporosis (stratum i)
boolean
C0013227 (UMLS CUI [1,1])
C3650929 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2,1])
C3650929 (UMLS CUI [2,2])
C0012544 (UMLS CUI [3,1])
C3650929 (UMLS CUI [3,2])
Anticonvulsants
Item
more than 12 months since prior and no concurrent anticonvulsants
boolean
C0003286 (UMLS CUI [1])
Adrenal Cortex Hormones Dose Daily | Prednisone Dose Daily | Prednisone Equivalent Dose Daily
Item
more than 6 months since prior and no concurrent corticosteroids at doses > 5 mg/day of prednisone (or equivalent) for > 2 weeks
boolean
C0001617 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0332173 (UMLS CUI [1,3])
C0032952 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0332173 (UMLS CUI [2,3])
C0032952 (UMLS CUI [3,1])
C0205163 (UMLS CUI [3,2])
C0178602 (UMLS CUI [3,3])
C0332173 (UMLS CUI [3,4])
Anabolic steroids
Item
more than 12 months since prior and no concurrent anabolic steroids
boolean
C0002744 (UMLS CUI [1])
Diphosphonates
Item
no prior bisphosphonates (stratum ii)
boolean
C0012544 (UMLS CUI [1])
Sodium Fluoride Dose Daily
Item
no concurrent sodium fluoride at daily doses ≥ 5 mg/day
boolean
C0037508 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0332173 (UMLS CUI [1,3])
Coumarins Long-term
Item
no long-term (i.e., > 6 months) use of coumarins
boolean
C0010207 (UMLS CUI [1,1])
C0443252 (UMLS CUI [1,2])
Pharmaceutical Preparations Prevention of osteoporosis | Investigational New Drugs Prevention of osteoporosis | Diphosphonates Prevention of osteoporosis | Osteopenia | Osteoporosis
Item
no concurrent drugs (investigational or not), including bisphosphonates, for the prevention of osteoporosis (for patients with no osteopenia or osteoporosis [stratum i])
boolean
C0013227 (UMLS CUI [1,1])
C3650929 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2,1])
C3650929 (UMLS CUI [2,2])
C0012544 (UMLS CUI [3,1])
C3650929 (UMLS CUI [3,2])
C0029453 (UMLS CUI [4])
C0029456 (UMLS CUI [5])